13.02.2019 • NewsBayerDede WillamsIndia

Bayer Wins a Monsanto Royalty Dispute

Bayer Wins a Monsanto Royalty Dispute (Photo by ‪Dima Visozki‬‏ from...
Bayer Wins a Monsanto Royalty Dispute (Photo by ‪Dima Visozki‬‏ from Pexels)

In a case involving the former Monsanto, Bayer has won a royalty dispute against Indian seeds producer Nuziveedu Seeds Limited (NSL), the news agency Reuters has reported.

Citing “lawyers familiar with the matter,” Reuters said NSL has the right to appeal the ruling in a court, the lawyers said.

Terms of the arbitration were not disclosed. Saying the award is “confidential,” Bayer confirmed to Reuters only that MMB “has received a favorable award from the arbitration panel in the proceedings against NSL and Prabhat”

MMB – a joint venture between the erstwhile US agrochemicals giant and India’s Maharashtra Hybrid Seeds Co (Mahyco) – reportedly had been seeking nearly $23 million.

Including NSL, the jv sells genetically modified (GM) cotton seeds under license to nearly 40 Indian seed companies, which in turn sell the products to retailers.

According to Reuters’ sources, NSL and its affiliates decided to stop paying royalties, or trait fees, to MMB in 2015, arguing that Indian law did not provide Monsanto with patent protection on its GM cotton seeds, and if there were to be payments they should be set by the Indian government.

In contrast, Monsanto had insisted it had patent protection in India and therefore could collect royalties through bilateral contracts with the Indian seed companies.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.